Cite
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer.
MLA
Farmer, Pierre, et al. “A Stroma-Related Gene Signature Predicts Resistance to Neoadjuvant Chemotherapy in Breast Cancer.” Nature Medicine, vol. 15, no. 1, Jan. 2009, pp. 68–74. EBSCOhost, https://doi.org/10.1038/nm.1908.
APA
Farmer, P., Bonnefoi, H., Anderle, P., Cameron, D., Wirapati, P., Becette, V., André, S., Piccart, M., Campone, M., Brain, E., MacGrogan, G., Petit, T., Jassem, J., Bibeau, F., Blot, E., Bogaerts, J., Aguet, M., Bergh, J., Iggo, R., & Delorenzi, M. (2009). A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nature Medicine, 15(1), 68–74. https://doi.org/10.1038/nm.1908
Chicago
Farmer, Pierre, Hervé Bonnefoi, Pascale Anderle, David Cameron, Pratyakasha Wirapati, Véronique Becette, Sylvie André, et al. 2009. “A Stroma-Related Gene Signature Predicts Resistance to Neoadjuvant Chemotherapy in Breast Cancer.” Nature Medicine 15 (1): 68–74. doi:10.1038/nm.1908.